Developing Picornaviruses for Cancer Therapy

Oncolytic viruses (OVs) form a group of novel anticancer therapeutic agents which selectively infect and lyse cancer cells. Members of several viral families, including <i>Picornaviridae</i>,<i> </i>have been shown to have anticancer activity. Picornaviruses are small icosahe...

Full description

Bibliographic Details
Main Authors: Cormac McCarthy, Nadishka Jayawardena, Laura N. Burga, Mihnea Bostina
Format: Article
Language:English
Published: MDPI AG 2019-05-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/11/5/685
Description
Summary:Oncolytic viruses (OVs) form a group of novel anticancer therapeutic agents which selectively infect and lyse cancer cells. Members of several viral families, including <i>Picornaviridae</i>,<i> </i>have been shown to have anticancer activity. Picornaviruses are small icosahedral non-enveloped, positive-sense, single-stranded RNA viruses infecting a wide range of hosts. They possess several advantages for development for cancer therapy: Their genomes do not integrate into host chromosomes, do not encode oncogenes, and are easily manipulated as cDNA. This review focuses on the picornaviruses<i> </i>investigated for anticancer potential and the mechanisms that underpin this specificity.
ISSN:2072-6694